loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Amantadine Sulphate

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Amantadine Sulphate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New Data Analysis Supports GOCOVRI for Motor Complications for People With PD
    New Data Analysis Supports GOCOVRI for Motor Complications for People With PD

    10 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210610005080/en

    BUSINESSWIRE
    10 Jun 2021
    Share Share
    Adamas' Parkinson's drug gets US marketing authorisation for second indication
    Adamas' Parkinson's drug gets US marketing authorisation for second indication

    01 Feb 2021

    // PHARMAFILE

    http://www.pharmafile.com/news/570439/adamas-parkinsons-drug-gets-us-marketing-authorisation-second-indication

    PHARMAFILE
    01 Feb 2021
    Share Share
    Adamas announces issuance of new U.S. patent for GOCOVRI
    Adamas announces issuance of new U.S. patent for GOCOVRI

    13 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/13/2032747/0/en/Adamas-announces-issuance-of-new-U-S-patent-for-GOCOVRI-in-Parkinson-s-disease-expands-coverage-with-reduction-of-OFF-time-and-increased-good-ON-time.html

    GLOBENEWSWIRE
    13 May 2020
    Share Share
    Gocovri™ (Amantadine) : Adamas Pharma, v. Sandoz
    Gocovri™ (Amantadine) : Adamas Pharma, v. Sandoz

    10 May 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/gocovri-amantadine-adamas-pharma-v-sandoz-1526283687.pdf

    PATENT LITIGATION
    10 May 2018
    Share Share